93 294 Pill - blue round, 10mm
Pill with imprint 93 294 is Blue, Round and has been identified as Carbidopa and Levodopa 25 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.
Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 294
Carbidopa and Levodopa
- Imprint
- 93 294
- Strength
- 25 mg / 250 mg
- Color
- Blue
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
corn starch,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-0294 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 63739-0048 (Discontinued) | McKesson Packaging Services |
Related images for "93 294"
More about carbidopa / levodopa
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (92)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Carbidopa and levodopa drug information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa () (Advanced Reading)
- Carbidopa and levodopa (Oral) (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
Other brands
Sinemet, Rytary, Sinemet CR, Dhivy, ... +2 more
Professional resources
- Levodopa/Carbidopa monograph
- Carbidopa and Levodopa (FDA)
- Carbidopa and Levodopa ODT (FDA)
- Carbidopa and Levodopa Tablets (FDA)
Other brands
Sinemet, Rytary, Sinemet CR, Dhivy, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
